News about

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-2 Manufacturing Facility

| 13/07/2023 | By 1098

Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility

Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility

Eli Lilly Selects ABEC for Single-Use Biopharma Manufacturing Facility

| 13/07/2023 | By 937

One-Stop Facility with cGMP Manufacturing to Bolster AMEAs Biopharma Industry

One-Stop Facility with cGMP Manufacturing to Bolster AMEAs Biopharma Industry

One-Stop Facility with cGMP Manufacturing to Bolster AMEA’s Biopharma Industry

| 13/07/2023 | By 905

Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag

Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag

Himachal delegation visits Jawaharlal Nehru Pharma City (JNPC), Vizag

| 11/07/2023 | By 1018

AD Ports Logistics, Acino sign freight forwarding agreement

AD Ports Logistics, Acino sign freight forwarding agreement

AD Ports Logistics, Acino sign freight forwarding agreement

| 11/07/2023 | By 461

Gujarat Alkalies and Chemicals Limited (GACL) Flags Off the first dispatch of import substitute Hydrazine Hydrate and Purified Phosphoric Acid

Gujarat Alkalies and Chemicals Limited (GACL) Flags Off the first dispatch of import substitute Hydrazine Hydrate and Purified Phosphoric Acid

Gujarat Alkalies and Chemicals Limited (GACL) Flags Off the first dispatch of import substitute Hydrazine Hydrate and Purified Phosphoric Acid<br />

| 11/07/2023 | By 1147

Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22

Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22

Aarti Drugs Limited wins Pharmexcil Outstanding Exports Awards 2021-22

| 10/07/2023 | By 1024

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

CuraTeQ obtains exclusive rights for BioFactura's Ustekinumab biosimilar

| 10/07/2023 | By 884

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

USFDA inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad concludes with nil observations

| 10/07/2023 | By 1523

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

| 10/07/2023 | By 942

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members